臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)

About TAIR
	About TAIR

Browse By
	Institution
	Author
	Title
	Date
	Statistics Chart
	Institution Facts
	Trend

News
	2019臺灣學術機構典藏研討會
	機構典藏系統RC7版本已發佈

Copyright
	Publisher & Journal Policy
	TAIR Copyright Conference Minutes

Related Links
	機構典藏計畫網站
	ROAR
	OpenDOAR
	SHERPA
	OAIster
	JAIRO
	Ira
	DSPACE
	RWWR
	臺大學術典藏NTU Scholars

"liang j t"

Return to Browse by Author
Sorting by Title	Sort by Date

Showing items 281-305 of 482 (20 Page(s) Totally)
<< < 7 8 9 10 11 12 13 14 15 16 > >>
View [10|25|50] records per page

Institution	Date	Title	Author
臺大學術典藏	2020-03-23T05:53:58Z	Three Nurse-administered Protocols Reduce Nutritional Decline and Frailty in Older Gastrointestinal Surgery Patients: A Cluster Randomized Trial	Huang J.; Tien Y.-W.; CHIUNG-NIEN CHEN; Lin M.-T.; Liang J.-T.; Li H.-C.; Huang G.-H.; Inouye S.K.; Yang C.-Y.; Lin B.-R.; Yang Y.-T.; Lai I.-R.; Chia-Hui Chen C.; Chia-Hui Chen C.;Yang Y.-T.;Lai I.-R.;Lin B.-R.;Yang C.-Y.;Huang J.;Tien Y.-W.;Chiung-Nien Chen;Lin M.-T.;Liang J.-T.;Li H.-C.;Huang G.-H.;Inouye S.K.
臺大學術典藏	2020-03-23T04:01:20Z	Volvulus of cecum: A case report and review of the literatures	Chang K.-J.; Lee W.-J.; MING-TSAN LIN; Liang J.-T.; Feng C.-Y.; Chang K.-J.;Lee W.-J.;MING-TSAN LIN;Liang J.-T.;Feng C.-Y.
臺大學術典藏	2020-03-23T04:00:47Z	Three Nurse-administered Protocols Reduce Nutritional Decline and Frailty in Older Gastrointestinal Surgery Patients: A Cluster Randomized Trial	MING-TSAN LIN; Liang J.-T.; Li H.-C.; Huang G.-H.; Inouye S.K.; Chen C.-N.; Huang J.; Tien Y.-W.; Yang C.-Y.; Yang Y.-T.; Lai I.-R.; Lin B.-R.; Chia-Hui Chen C.; Chia-Hui Chen C.;Yang Y.-T.;Lai I.-R.;Lin B.-R.;Yang C.-Y.;Huang J.;Tien Y.-W.;Chen C.-N.;Ming-Tsan Lin;Liang J.-T.;Li H.-C.;Huang G.-H.;Inouye S.K.
臺大學術典藏	2020-03-07T06:56:33Z	Oxaliplatin-based chemotherapy might provide longer progression-free survival in KRAS mutant metastatic colorectal cancer	YIH-LEONG CHANG; Yeh K.-H.; Cheng A.-L.; Lin Y.-L.; Liau J.-Y.; Yu S.-C.; Tseng L.-H.; Lin L.-I.; Liang J.-T.; Lin B.-R.; Hung J.-S.
臺大學術典藏	2020-03-07T06:56:25Z	Oxaliplatin-based chemotherapy is more beneficial in KRAS mutant than in KRAS wild-type metastatic colorectal cancer patients	YIH-LEONG CHANG; Yeh K.-H.; Cheng A.-L.; Tseng L.-H.; Lin L.-I.; Hung J.-S.; Lin B.-R.; Liau J.-Y.; Liang J.-T.; Tsai J.-H.; Liang Y.-H.; Lin Y.-.; Lin Y.-.;Liang Y.-H.;Tsai J.-H.;Liau J.-Y.;Liang J.-T.;Lin B.-R.;Hung J.-S.;Lin L.-I.;Tseng L.-H.;Yih-Leong Chang;Yeh K.-H.;Cheng A.-L.
臺大學術典藏	2020-03-07T06:56:23Z	Cetuximab might be detrimental to metastatic colorectal cancer patients with KRAS codon 12 mutations	Liang Y.-H.;Lin Y.-L.;Liau J.-Y.;Tsai J.-H.;Liang J.-T.;Lin B.-R.;Hung J.-S.;Tseng L.-H.;Lin L.-I.;Yih-Leong Chang;Cheng A.-L.;Yeh K.-H.; Liang Y.-H.; Lin Y.-L.; Liau J.-Y.; Tsai J.-H.; Liang J.-T.; Lin B.-R.; Hung J.-S.; Tseng L.-H.; Lin L.-I.; YIH-LEONG CHANG; Cheng A.-L.; Yeh K.-H.
臺大學術典藏	2020-03-07T06:56:18Z	BRAF mutation may have different prognostic implications in early- and late-stage colorectal cancer	Tseng L.-H.; Lin L.-I.; Liang J.-T.; Lin B.-R.; Hung J.-S.; YIH-LEONG CHANG; Yeh K.-H.; Cheng A.-L.; Chen K.-H.;Lin Y.-L.;Liau J.-Y.;Tsai J.-H.;Tseng L.-H.;Lin L.-I.;Liang J.-T.;Lin B.-R.;Hung J.-S.;Yih-Leong Chang;Yeh K.-H.;Cheng A.-L.; Chen K.-H.; Lin Y.-L.; Liau J.-Y.; Tsai J.-H.
臺大學術典藏	2020-03-06T08:25:40Z	Clinicopathological and molecular biological features of colorectal cancer in patients less than 40 years of age	Liang J.T.;Huang K.C.;Cheng A.L.;Yung-Ming Jeng;Wu M.S.;Wang S.M.; Liang J.T.; Huang K.C.; Cheng A.L.; YUNG-MING JENG; Wu M.S.; Wang S.M.
臺大學術典藏	2020-03-06T08:25:40Z	Comparison of medial-to-lateral versus traditional lateral-to-medial laparoscopic dissection sequences for resection of rectosigmoid cancers: Randomized controlled clinical trial	Liang J.-T.;Lai H.-S.;Huang K.-C.;Chang K.-J.;Shieh M.-J.;Yung-Ming Jeng;Wang S.-M.; Liang J.-T.; Lai H.-S.; Wang S.-M.; YUNG-MING JENG; Shieh M.-J.; Huang K.-C.; Chang K.-J.
臺大學術典藏	2020-03-06T08:25:38Z	Microvessel density, cyclo-oxygenase 2 expression, K-ras mutation and p53 overexpression in colonic cancer	Liang J.-T.; Huang K.-C.; YUNG-MING JENG; Lee P.-H.; Lai H.-S.; Hsu H.-C.; Liang J.-T.;Huang K.-C.;Yung-Ming Jeng;Lee P.-H.;Lai H.-S.;Hsu H.-C.
臺大學術典藏	2020-03-06T08:25:36Z	Connective tissue growth factor inhibits metastasis and acts as an independent prognostic marker in colorectal cancer	Chen S.-T.; Chen R.J.-C.; Yang C.-Y.; YUNG-MING JENG; Liang J.-T.; Lee P.-H.; Chang K.-J.; Chau Y.-P.; Kuo M.-L.; Lin B.-R.;Chang C.-C.;Che T.-F.;Chen S.-T.;Chen R.J.-C.;Yang C.-Y.;Yung-Ming Jeng;Liang J.-T.;Lee P.-H.;Chang K.-J.;Chau Y.-P.;Kuo M.-L.; Lin B.-R.; Chang C.-C.; Che T.-F.
臺大學術典藏	2020-03-06T08:25:30Z	Oncologic results of laparoscopic versus conventional open surgery for stage II or III left-sided colon cancers: A randomized controlled trial	Liang J.-T.;Huang K.-C.;Lai H.-S.;Lee P.-H.;Yung-Ming Jeng; Liang J.-T.; Huang K.-C.; Lai H.-S.; Lee P.-H.; YUNG-MING JENG
臺大學術典藏	2020-03-06T08:25:18Z	Connective tissue growth factor acts as a therapeutic agent and predictor for peritoneal carcinomatosis of colorectal cancer	Lin B.-R. ;Chang C.-C. ;Chen R.J.-C. ;Yung-Ming Jeng ;Liang J.-T. ;Lee P.-H. ;Chang K.-J. ;Kuo M.-L.; Lin B.-R.; Chang C.-C.; Chen R.J.-C.; YUNG-MING JENG; Liang J.-T.; Lee P.-H.; Chang K.-J.; Kuo M.-L.
臺大學術典藏	2020-03-06T08:25:14Z	Prognostic significance of TWEAK expression in colorectal cancer and effect of its inhibition on invasion	Lin B.-R.;Huang M.-T.;Chen S.-T.;Yung-Ming Jeng;Li Y.-J.;Liang J.-T.;Lee P.-H.;Chang K.-J.;Chang C.-C.; Lin B.-R.; Huang M.-T.; Chen S.-T.; YUNG-MING JENG; Li Y.-J.; Liang J.-T.; Lee P.-H.; Chang K.-J.; Chang C.-C.
臺大學術典藏	2020-03-06T08:24:53Z	Treatment outcomes regarding the addition of targeted agents in the therapeutic portfolio for stage II-III rectal cancer undergoing neoadjuvant chemoradiation	Liang J.-T.;Chen T.-C.;Huang J.;Yung-Ming Jeng;Cheng J.C.-H.; Liang J.-T.; Chen T.-C.; Huang J.; YUNG-MING JENG; Cheng J.C.-H.
臺大學術典藏	2020-03-06T05:26:20Z	Oxaliplatin-based chemotherapy might provide longer progression-free survival in KRAS mutant metastatic colorectal cancer	Lin Y.-L.; Liau J.-Y.; Yu S.-C.; Tseng L.-H.; Lin L.-I.; Liang J.-T.; Lin B.-R.; Hung J.-S.; YIH-LEONG CHANG; Yeh K.-H.; Cheng A.-L.
臺大學術典藏	2020-03-06T05:26:15Z	Oxaliplatin-based chemotherapy is more beneficial in KRAS mutant than in KRAS wild-type metastatic colorectal cancer patients	Lin Y.-.; Liang Y.-H.; Tsai J.-H.; Liau J.-Y.; Liang J.-T.; Lin B.-R.; Hung J.-S.; Lin L.-I.; Tseng L.-H.; YIH-LEONG CHANG; Yeh K.-H.; Cheng A.-L.
臺大學術典藏	2020-03-06T05:26:12Z	Cetuximab might be detrimental to metastatic colorectal cancer patients with KRAS codon 12 mutations	Liang Y.-H.; Lin Y.-L.; Liau J.-Y.; Tsai J.-H.; Liang J.-T.; Lin B.-R.; Hung J.-S.; Tseng L.-H.; Lin L.-I.; YIH-LEONG CHANG; Cheng A.-L.; Yeh K.-H.
臺大學術典藏	2020-03-06T05:26:09Z	BRAF mutation may have different prognostic implications in early- and late-stage colorectal cancer	Chen K.-H.; Lin Y.-L.; Liau J.-Y.; Tsai J.-H.; Tseng L.-H.; Lin L.-I.; Liang J.-T.; Lin B.-R.; Hung J.-S.; YIH-LEONG CHANG; Yeh K.-H.; Cheng A.-L.
臺大學術典藏	2020-03-05T12:22:25Z	Oxaliplatin-based chemotherapy might provide longer progression-free survival in KRAS mutant metastatic colorectal cancer	Lin Y.-L.; Liau J.-Y.; SHAN-CHI YU; Tseng L.-H.; Lin L.-I.; Liang J.-T.; Lin B.-R.; Hung J.-S.; Chang Y.-L.; Yeh K.-H.; Cheng A.-L.
臺大學術典藏	2020-03-05T08:16:42Z	Overexpression of MUC15 activates extracellular signal-regulated kinase 1/2 and promotes the oncogenic potential of human colon cancer cells	Huang J.; Che M.-I.; Huang Y.-T.; Shyu M.-K.; Huang Y.-M.; Wu Y.-M.; Lin W.-C.; PEI-HSIN HUANG; Liang J.-T.; Lee P.-H.; Huang M.-C.
臺大學術典藏	2020-03-05T07:31:48Z	Oxaliplatin-based chemotherapy is more beneficial in KRAS mutant than in KRAS wild-type metastatic colorectal cancer patients	Lin Y.-.;Liang Y.-H.;Jia-Huei Tsai;Liau J.-Y.;Liang J.-T.;Lin B.-R.;Hung J.-S.;Lin L.-I.;Tseng L.-H.;Chang Y.-L.;Yeh K.-H.;Cheng A.-L.; Lin Y.-.; Liang Y.-H.; JIA-HUEI TSAI; Liau J.-Y.; Liang J.-T.; Lin B.-R.; Hung J.-S.; Lin L.-I.; Tseng L.-H.; Chang Y.-L.; Yeh K.-H.; Cheng A.-L.
臺大學術典藏	2020-03-05T07:31:46Z	Cetuximab might be detrimental to metastatic colorectal cancer patients with KRAS codon 12 mutations	Liang Y.-H.;Lin Y.-L.;Liau J.-Y.;Jia-Huei Tsai;Liang J.-T.;Lin B.-R.;Hung J.-S.;Tseng L.-H.;Lin L.-I.;Chang Y.-L.;Cheng A.-L.;Yeh K.-H.; Liang Y.-H.; Lin Y.-L.; Liau J.-Y.; Yeh K.-H.; Cheng A.-L.; Chang Y.-L.; Lin L.-I.; Tseng L.-H.; JIA-HUEI TSAI; Liang J.-T.; Lin B.-R.; Hung J.-S.
臺大學術典藏	2020-03-05T07:31:45Z	BRAF mutation may have different prognostic implications in early- and late-stage colorectal cancer	Chen K.-H.; Lin Y.-L.; Liau J.-Y.; JIA-HUEI TSAI; Tseng L.-H.; Lin L.-I.; Liang J.-T.; Lin B.-R.; Hung J.-S.; Chang Y.-L.; Yeh K.-H.; Cheng A.-L.
臺大學術典藏	2020-03-05T06:28:43Z	Oxaliplatin-based chemotherapy might provide longer progression-free survival in KRAS mutant metastatic colorectal cancer	Cheng A.-L.; Yeh K.-H.; Chang Y.-L.; Hung J.-S.; Lin Y.-L.; JAU-YU LIAU; Yu S.-C.; Tseng L.-H.; Lin L.-I.; Liang J.-T.; Lin B.-R.

Showing items 281-305 of 482 (20 Page(s) Totally)
<< < 7 8 9 10 11 12 13 14 15 16 > >>
View [10|25|50] records per page

	English \| 正體中文 \| 简体中文 \| Total items :0
	Visitors : 52177792 Online Users : 776 Project Commissioned by the Ministry of Education Project Executed by National Taiwan University Library